Broad‐Spectrum Antibacterial Activity of Postbiotic From Lacticaseibacillus paracasei BGP1 Against Multidrug‐Resistant Skin Wound Pathogens
Open Access
- 8 December 2025
- journal article
- Published by Wiley in Microbiologyopen
- Vol. 14 (6) , e70137
Abstract
The increasing problem of antibiotic resistance indicates the need for alternative therapeutic strategies for skin wound infections. While probiotics exhibit potential for developing such alternatives, the majority of antimicrobial studies focus on live cells or lysates and oral delivery. Notably, in dermatology, formulating products with live strains poses technical challenges due to stability issues in water‐based systems. Postbiotics, substances made from probiotics, offer a promising, stable, and safe alternative. This study addresses the gap by evaluating the antibacterial potential of cell‐free supernatants (CFSs) from six probiotic strains, with a specific focus on Lacticaseibacillus paracasei BGP1, against clinically relevant skin pathogens. CFSs were screened in vitro using agar well diffusion and broth microdilution assays against Staphylococcus aureus ATCC 25923, methicillin‐resistant S. aureus (MRSA; UTMC 1442), Pseudomonas aeruginosa ATCC 27853, and P. aeruginosa PAO1. GC‐MS analysis was used to identify bioactive compounds in the most promising CFS. Among the tested strains, BGP1 demonstrated both consistent inhibitory (MIC: 6.25 mg/mL) and bactericidal (MBC: 12.5 mg/mL) effects. GC‐MS analysis identified palmitic acid (33.24%) and stearic acid (46.45%) as dominant bioactive compounds. These findings provide novel evidence that postbiotic metabolites from L. paracasei BGP1 represent a promising, broad‐spectrum, stable, and nonliving candidate to conventional therapies for antibiotic‐resistant skin wound infections. Further in vivo research is needed to evaluate their therapeutic potential and formulation in clinical settings.Keywords
This publication has 82 references indexed in Scilit:
- Compounds fromLactobacillus plantarumculture supernatants with potential pro-healing and anti-pathogenic properties in skin chronic woundsPharmaceutical Biology, 2014
- Lactobacillus acidophilusNCFM affects vitamin E acetate metabolism and intestinal bile acid signature in monocolonized miceGut Microbes, 2014
- Optimization and production of pyrrolidone antimicrobial agent from marine sponge-associated Streptomyces sp. MAPS15Bioprocess and Biosystems Engineering, 2013
- In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: Evidence for the effects of organic acidsAnaerobe, 2012
- Production of Organic Acids by Probiotic Lactobacilli Can Be Used to Reduce Pathogen Load in PoultryPLOS ONE, 2012
- Purification and genetic characterisation of the novel bacteriocin LS2 produced by the human oral strain Lactobacillus salivarius BGHO1International Journal of Antimicrobial Agents, 2012
- Stress, Sublethal Injury, Resuscitation, and Virulence of Bacterial Foodborne PathogensJournal of Food Protection, 2009
- New Consensus Guidelines from the Clinical and Laboratory Standards Institute for Antimicrobial Susceptibility Testing of Infrequently Isolated or Fastidious BacteriaClinical Infectious Diseases, 2007
- Probiotics: facts and mythsClinical Microbiology and Infection, 2005
- Weak Organic Acids: A Panoply of Effects on BacteriaScience Progress, 2003